7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16343 | NRC-2694 | EGFR | |
NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties. | |||
T26625 | AN-019 | NRC-AN-019,NRC-019 | Bcr-Abl |
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer. | |||
T71332 | NRC-2694 hydrochloride | ||
NRC-2694 hydrochloride is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors. | |||
T71331 | NRC-2694 dihydrochloride | ||
NRC-2694 dihydrochloride is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors. | |||
T81644 | NRC-16 | ||
NRC-16 is a biologically active peptide with characteristics similar to pleurocidin, a cationic antimicrobial peptide (cationic AMP). | |||
T71985 | ID110460002 | ||
ID110460002 is a novel μ,δ-Opioid Receptor Dual-Biased Agonist, Overcoming the Limitation of Prior Biased Agonist. | |||
T71330 | Bexin-1 | ||
Bexin-1 is an inhibitor of Munc13-4 membrane binding which targets the Munc13-4 C2 domain-membrane interface, and inhibits ionomycin-stimulated ANF-EGFP secretion. |